Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Bay Community Bancorp Earns $1.31 Million in Fourth Quarter 2023 and a Record $8.23 Million for the Year; Declares Quarterly Cash Dividend of $0.05 Per Share
-
Aether Fuels and GTI Energy Announce Partnership and Exclusive Licensing Deal to Accelerate Commercialization of Sustainable Fuels for Aviation and Ocean Shipping
-
Dresner Advisory Services Publishes 2024 Generative AI Report
-
First Patient Enrollment into Aspero Medical NIH-Funded Study
-
Introducing Grandie: The Revolutionary Artificial Intelligence (AI) Enabled Virtual Companion for Seniors on GrandPad
-
PeopleOne, Eleviant-CTG's Intranet Platform, Recognized in the 2024 ClearBox Intranet and Employee Experience Report
-
Canada-based Cinim included as part of international digital series, In Pursuit of Wellness
-
Researchers at KFSH&RC & KAUST Discover Gene Responsible for Reproduction of the Most Dangerous Malaria Strain
-
Safe and Green Development Corporation Executes Contract to Sell St Mary’s Site for $1.35M
-
Intelligent Bio Solutions Inc. Announces Exercise of Previously Issued Warrants for $1.77 Million in Gross Proceeds
-
Yiviva Announces Memorandum of Understanding with AstraZeneca to Develop Platforms, Technologies, and Innovative Therapeutics through a Systems Biology Approach
-
Spectral AI Announces Publication of Letter to Shareholders
-
Idaho National Laboratory Completes Pre-Conceptual Review of NANO Nuclear Energy’s Proprietary Low-Pressure Coolant Microreactor “ODIN”
-
ProLynx announces initiation of Phase I/II clinical trial of its DNA-damaging agent PLX038 in patients with rare CNS tumors at the National Cancer Institute (NCI)
-
Riot Announces January 2024 Production and Operations Updates
-
Verizon advances O-RAN technology by deploying 130,000 new O-RAN capable radios in its network
-
Phoenix-Based Marketing and Communications Agency Highnoon Rebrands as Agital
-
Curia Receives 2024 CDMO Leadership Award
-
Kaiser Aluminum Announces Fourth Quarter and Full Year 2023 Earnings Release and Conference Call
-
VEON and Kyivstar set in motion their 600m USD investment plan with Kyiv visit, Mike Pompeo joins the delegation
-
Decatur Children’s Book Festival announces keynote speaker, Kate DiCamillo
-
Researchers at KFSH&RC & KAUST Discover Gene Responsible for Reproduction of the Most Dangerous Malaria Strain
-
Transactions in connection with share buyback programme
-
Rail Vision Receives Patent Approval from the Indian Patent Office
-
MangoRx Accepting Pre Orders for its “PRIME”, by MangoRx, Powered by Kyzatrex®️ FDA Approved Oral Testosterone Replacement Therapy (TRT) Product
-
PodcastOne Renews Agreement with Kelly Stafford’s The Morning After with Kelly Stafford & Hank Podcast
-
Atico Reports High Grade Intercepts up to 4.45m of 5.17% Cu, 10.47g/t Au and 4.90m of 9.35% Cu, 2.94 g/t Au and Continues to Extend the Ore Body at El Roble Mine in Colombia
-
OMNIQ ANNOUNCES THE ACQUISITION OF CODEBLOCKS LTD A LEADING FINTECH SOFTWARE DEVELOPER
-
PodcastOne Renews Agreement with Kelly Stafford’s The Morning After with Kelly Stafford & Hank Podcast
-
Conduent to Report Fourth-Quarter and Full-Year 2023 Financial Results on Feb. 14, 2024
-
Wreaths Across America Welcomes Military Spouse Noreen O’Neil to Development Team
-
AITX’s RAD Announces that Major Order Arrives Ahead of Schedule from Fortune 50 Client
-
Form 8.3 - Smart Metering Systems plc
-
Stifel Named US Mid-Market Equity House of the Year by International Financing Review
-
Middlefield Real Estate Dividend ETF Achieves Fundata FundGrade A+®
-
Virtú Investments Acquires Multifamily Property via Contribution into Virtú Evergreen Fund, L.P.
-
Supernus Wins Infringement and Validity Case on Trokendi XR® against Torrent
-
CEMATRIX Announces New Chief Financial Officer
-
InterDigital Announces Convertibility of 3.50% Senior Convertible Notes Due 2027
-
Treasure Global CEO Demonstrates Confidence in Company's Future Through Share Purchase
-
LiveOne (NASDAQ: LVO) Subsidiary Splitmind Wins Grammy
-
Chiesi Global Rare Diseases Announces Health Canada Approval of MYALEPTA™ (metreleptin for injection) for the Treatment of Patients with Lipodystrophy
-
Treasure Global CEO Demonstrates Confidence in Company's Future Through Share Purchase
-
LiveOne (NASDAQ: LVO) Subsidiary Splitmind Wins Grammy
-
Blüm Holdings Refocuses on Cannabis Retail and Brand Leadership with Strategic Sale of Cultivation Assets
-
Elicio Therapeutics to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
-
Verizon’s commitment to the Las Vegas community goes far beyond supporting the Big Game
-
Vericel to Present at the Canaccord Genuity Musculoskeletal Conference on Monday, February 12, 2024
-
eFFECTOR Therapeutics to Present at Oppenheimer 34th Annual Healthcare Life Sciences Conference
-
Foresight Successfully Completes Project with Prominent Japanese Vehicle Manufacturer
